Bipolar disorder

BMJ (Online)

Volumn 346, Issue 7889, 2013, Pages

  Anderson, Ian M ^a   Haddad, Peter M ^a,b   Scott, Jan ^c,d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CLOZAPINE; FLUOXETINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRANQUILIZER; VALPROIC ACID;

ALCOHOLISM; ALLELE; ANXIETY DISORDER; BEHAVIOR DISORDER; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; CYCLOTHYMIA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG DEPENDENCE; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; EUPHORIA; EVIDENCE BASED MEDICINE; EXECUTIVE FUNCTION; FAMILY THERAPY; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; HYPOMANIA; INSOMNIA; LONG TERM CARE; MAJOR DEPRESSION; MANIA; MATERNAL CARE; MENTAL HEALTH; NEUROLOGIC EXAMINATION; ONSET AGE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT REFERRAL; PHENOTYPE; PHYSICAL ABUSE; PREGNANCY; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOEDUCATION; PSYCHOTHERAPY; QUESTIONNAIRE; RAPID CYCLING BIPOLAR DISORDER; RELAPSE; RESTLESSNESS; REVIEW; SCREENING; SELF EVALUATION; SEX DIFFERENCE; SEXUAL ABUSE; SOCIAL STRESS; TERATOGENICITY; TREATMENT RESPONSE;

EID: 84872297583     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e8508     Document Type: Review

References (43)

1. Nordentoft M, Mortensen PB, Pedersen CB. Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry 2011;68:1058-64.
2. Johnson SL, Morriss R, Scott J, Paykel E, Kinderman P, Kolamunnage-Dona R,et al. Depressive and manic symptoms are not opposite poles in bipolar disorder. Acta Psychiatr Scand 2011;123:206-10.
3. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA,et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011;68:241-51.
4. Malhi GS, Chengappa KN, Gershon S, Goldberg JF. Hypomania: hype or mania? Bipolar Disord 2010;12:758-63.
5. Benazzi F. Is there a continuity between bipolar and depressive disorders? Psychother Psychosom 2007;76:70-6.
6. Duffy A, Alda M, Hajek T, Sherry SB, Grof P. Early stages in the development of bipolar disorder. J Affect Disord 2010;121:127-35.
7. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 2012;13:537-51.
8. Etain B, Henry C, Bellivier F, Mathieu F, Leboyer M. Beyond genetics: childhood affective trauma in bipolar disorder. Bipolar Disord 2008;10:867-76.
9. Martinowich K, Schloesser RJ, Manji HK. Bipolar disorder: from genes to behavior pathways. J Clin Invest 2009;119:726-36.
10. Latalova K. Insight in bipolar disorder. Psychiatr Q 2012;83:293-310.
11. Judd LL, Schettler PJ, Akiskal HS, Maser J, Coryell W, Solomon D,et al. Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int J Neuropsychopharmacol 2003;6:127-37.
12. Howes OD, Falkenberg I. Early detection and intervention in bipolar affective disorder: targeting the development of the disorder. Curr Psychiatry Rep 2011;13:493-9.
13. Wittchen HU, Mhlig S, Pezawas L. Natural course and burden of bipolar disorders. Int J Neuropsychopharmacol 2003;6:145-54.
14. Correa R, Akiskal H, Gilmer W, Nierenberg AA, Trivedi M, Zisook S. Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression? J Affect Disord 2010;127:10-8.
15. Bora E, Harrison BJ, Yucel M, Pantelis C. Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol Med 2012; published online 26 October.
16. Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord 2010;12:1-9.
17. Roshanaei-Moghaddam B, Katon W. Premature mortality from general medical illnesses among persons with bipolar disorder: a review. Psychiatr Serv 2009;60:147-56.
18. Goodwin GM. Evidence-based guidelines for treating bipolar disorder: revised second edition - recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009;23:346-88.
19. National Institute for Health and Clinical Excellence. Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care. CG38. 2006. www.nice.org.uk/cg38.
20. Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr,et al. Development and validation of a screening instrument for bipolar spectrum disorder: the mood disorder questionnaire. Am J Psychiatry 2000;157:1873-5.
21. Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD,et al. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord 2005;88:217-33.
22. Mitchell PB, Goodwin GM, Johnson GF, Hirschfeld RM. Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disord 2008;10:144-52.
23. Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S,et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet 2011;378:1306-15.
24. Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D. Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy. Acta Psychiatr Scand 2007;115:12-20.
25. Vieta E, Locklear J, Gunther O, Ekman M, Miltenburger C, Chatterton ML,et al. Treatment options for bipolar depression: a systematic review of randomized, controlled trials. J Clin Psychopharmacol 2010;30:579-90.
26. Sidor MM, Macqueen GM. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. J Clin Psychiatry 2011;72:156-67.
27. Vieta E, Gunther O, Locklear J, Ekman M, Miltenburger C, Chatterton ML,et al. Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol 2011;14:1029-49.
28. Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R,et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004;65:432-41.
29. Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ,et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010;375:385-95.
30. Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O'Donovan C,et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009;11:225-55.
31. Hollon SD, Ponniah K. A review of empirically supported psychological therapies for mood disorders in adults. Depress Anxiety 2010;27:891-932.
32. Anaya C, Martinez AA, Ayuso-Mateos JL, Wykes T, Vieta E, Scott J. A systematic review of cognitive remediation for schizo-affective and affective disorders. J Affect Disord 2012;142:13-21.
33. Miklowitz DJ, Scott J. Psychosocial treatments for bipolar disorder: cost-effectiveness, mediating mechanisms, and future directions. Bipolar Disord 2009;11(suppl 2):110-22.
34. Tondo L, Vazquez G, Baldessarini RJ. Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatr Scand 2010;121:404-14.
35. Muller-Oerlinghausen B, Retzow A, Henn FA, Giedke H, Walden J. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group. J Clin Psychopharmacol 2000;20:195-203.
36. Sajatovic M, Valenstein M, Blow F, Ganoczy D, Ignacio R. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv 2007;58:855-63.
37. Weisler RH, Nolen WA, Neijber A, Hellqvist A, Paulsson B. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study). J Clin Psychiatry 2011;72:1452-64.
38. Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005;162:1805-19.
39. National Patient Safety Agency. Safer lithium therapy. Patient safety alert NPSA/2009/PSA005. 2009. www.nrls.npsa.nhs.uk/resources/type/alerts/? entryid45=65426&q=0%c2%aclithium%c2%ac.
40. Goodwin GM. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry 1994;164:149-52.
41. Sharma V, Pope CJ. Pregnancy and bipolar disorder: a systematic review. J Clin Psychiatry 2012;73:1447-55.
42. Dierckx B, Heijnen WT, van den Broek WW, Birkenhager TK. Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis. Bipolar Disord 2012;14:146-50.
43. Treuer T, Tohen M. Predicting the course and outcome of bipolar disorder: a review. Eur Psychiatry 2010;25:328-33.